Companies Dominating the Orthobiologics Landscape
- Medtronic plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
- Arthrex, Inc.
- Medical Device Business Services, Inc.
- Johnson & Johnson & Services, Inc.
- RTI Surgical, Inc.
- MTG Learning Media Pvt. Ltd.
- Bioventus LLC
- Stryker Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Orthobiologics Market is assessed at USD 8.85 billion.
The global orthobiologics market size was valued at over USD 8.46 billion in 2024 and is projected to grow at a robust CAGR of 5.7%, surpassing USD 17.39 billion by 2037.
North America is likely to hold the top spot, impelled by a rising geriatric population and increased healthcare expenditure.
The major players in the market include Wright Medical Group N.V., Zimmer Biomet Holdings, Inc., Arthrex, Inc., Medical Device Business Services, Inc., Johnson & Johnson & Services, Inc., RTI Surgical, Inc., MTG Learning Media Pvt. Ltd., and others.
